Literature DB >> 14524655

Collaborative drug therapy management by pharmacists--2003.

Raymond W Hammond1, Amy H Schwartz, Marla J Campbell, Tami L Remington, Susan Chuck, Melissa M Blair, Ann M Vassey, Raylene M Rospond, Sheryl J Herner, C Edwin Webb.   

Abstract

Since publication of the initial ACCP position statement on CDTM by pharmacists in 1997, the public, government, and much of the health care community at large have come to better appreciate the growing complexity of providing effective and safe drug therapy in today's health care environment. Increased interest in the issues of cost and quality of drug use is evident in the increasing coverage of the issue in the lay press and professional literature. This represents real progress, as well as real opportunity, for pharmacists. It also heightens the potential for a better understanding of the vital role that pharmacists can play in addressing these concerns. The percentage of patients who take several drugs for chronic diseases will continue to increase. Based on current trends, the number of patients who lack adequate access to care, or who receive either suboptimal, inappropriate, or unnecessarily expensive drug therapy for their acute and chronic diseases, will increase. Even as financial and human resources are increasingly strained within the current health care system, costs will continue to rise unless changes are made. Fortunately, qualified pharmacists are prepared, capable, and willing to help address a significant portion of these challenges. The public, many health care providers, some legislators, and a few insurers now recognize that pharmacists, because of their education and training in drug therapy, are well positioned both to accept additional responsibility for patient care and to provide services that make a real difference in health care quality and outcomes. The health care programs administered by the U.S. Public Health Service, the armed forces, and the Veterans Health Administration, as well as 38 states, now support pharmacist participation in CDTM. Pharmacists, working in an interdisciplinary structure with physicians and other health care providers, have demonstrated that they can improve the effectiveness, efficiency, and safety of drug therapy by providing CDTM. It is time to incorporate this valuable professional skill of the contemporary pharmacist as a core component of the delivery of health care services.

Entities:  

Mesh:

Year:  2003        PMID: 14524655     DOI: 10.1592/phco.23.10.1210.32752

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  36 in total

1.  Prescribing by pharmacists: information paper (2009).

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-05

2.  Pharmacists' changing views of their supplementary prescribing authority.

Authors:  Mary P Tully; Saima Latif; Judith A Cantrill; Dianne Parker
Journal:  Pharm World Sci       Date:  2007-03-23

3.  Community pharmacists in Khartoum State, Sudan: their current roles and perspectives on pharmaceutical care implementation.

Authors:  Alnada Ibrahim; Jenny Scott
Journal:  Int J Clin Pharm       Date:  2012-12-20

Review 4.  Review of community pharmacy staff educational needs for supporting mental health consumers and carers.

Authors:  Amary Mey; Jane L Fowler; Kathy Knox; David H K Shum; Jasmina Fejzic; Laetitia Hattingh; Denise McConnell; Amanda Wheeler
Journal:  Community Ment Health J       Date:  2013-01-10

5.  An expanded prescribing role for pharmacists - an Australian perspective.

Authors:  Kreshnik Hoti; Jeffery Hughes; Bruce Sunderland
Journal:  Australas Med J       Date:  2011-04-30

6.  Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists.

Authors:  Kreshnik Hoti; Jeffery Hughes; Bruce Sunderland
Journal:  Int J Clin Pharm       Date:  2013-04-03

7.  Achieving pharmacy-based public health: a call for public health engagement.

Authors:  Beth E Meyerson; Priscilla T Ryder; Carriann Richey-Smith
Journal:  Public Health Rep       Date:  2013 May-Jun       Impact factor: 2.792

8.  Perceived value of ward-based pharmacists from the perspective of physicians and nurses.

Authors:  Ulrika Gillespie; Claes Mörlin; Margareta Hammarlund-Udenaes; Mariann Hedström
Journal:  Int J Clin Pharm       Date:  2012-01-03

9.  Pharmacist-led, interdisciplinary model for delivery of supportive care in the ambulatory cancer clinic setting.

Authors:  John Valgus; Sandra Jarr; Robert Schwartz; Michelle Rice; Stephen A Bernard
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

10.  High-Dose, Extended-Interval Gentamicin and Tobramycin for Pediatric Inpatients: A Survey of Canadian Hospital Pharmacists.

Authors:  Caitlin Roy; Carolyn Gray; Lisa Ruda; Ali Bell; Jennifer Bolt
Journal:  Can J Hosp Pharm       Date:  2016-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.